Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-28 07:57 am Unchanged |
2025-02-27 | 13G | BioRestorative Therapies, Inc. BRTX |
Morrison Todd Hale | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-02-19 4:43 pm Purchase |
2025-02-14 | 13D | BioRestorative Therapies, Inc. BRTX |
Silva, Francisco | 1,196,819 15.100% |
432,262 (+56.54%) |
Filing History |
| 2025-02-19 4:39 pm Purchase |
2025-02-14 | 13D | BioRestorative Therapies, Inc. BRTX |
ALSTODT LANCE | 1,236,809 15.500% |
437,673 (+54.77%) |
Filing History |
| 2025-02-19 07:54 am Unchanged |
2025-02-18 | 13G | BioRestorative Therapies, Inc. BRTX |
Morrison Todd Hale | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-02-10 4:29 pm Unchanged |
2025-02-10 | 13G | BioRestorative Therapies, Inc. BRTX |
Morrison Todd Hale | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-12-05 5:37 pm Sale |
2024-06-12 | 13G | BioRestorative Therapies, Inc. BRTX |
Morrison Todd Hale | 0 0.000% |
-550,000 (Position Closed) |
Filing History |
| 2024-11-14 12:33 pm Purchase |
2024-09-30 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 692,418 9.900% |
210,103 (+43.56%) |
Filing History |
| 2024-06-21 6:33 pm Purchase |
2024-06-12 | 13G | BioRestorative Therapies, Inc. BRTX |
Morrison Todd Hale | 550,000 8.100% |
550,000 (New Position) |
Filing History |
| 2024-03-06 4:34 pm Purchase |
2024-02-08 | 13D | BioRestorative Therapies, Inc. BRTX |
Broadrick Dale | 926,376 14.100% |
314,631 (+51.43%) |
Filing History |
| 2024-02-15 4:43 pm Purchase |
2024-02-13 | 13D | BioRestorative Therapies, Inc. BRTX |
Silva, Francisco | 764,557 10.700% |
764,557 (New Position) |
Filing History |
| 2024-02-15 4:40 pm Purchase |
2024-02-13 | 13D | BioRestorative Therapies, Inc. BRTX |
ALSTODT LANCE | 799,136 11.200% |
799,136 (New Position) |
Filing History |
| 2024-02-14 1:44 pm Purchase |
2023-12-31 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 482,315 9.900% |
106,311 (+28.27%) |
Filing History |
| 2023-02-17 5:25 pm Purchase |
2023-02-17 | 13D | BioRestorative Therapies, Inc. BRTX |
Silva, Francisco | 505,125 12.500% |
356,198 (+239.18%) |
Filing History |
| 2023-02-17 5:24 pm Purchase |
2023-02-17 | 13D | BioRestorative Therapies, Inc. BRTX |
ALSTODT LANCE | 513,784 12.700% |
362,366 (+239.32%) |
Filing History |
| 2023-02-14 1:02 pm Purchase |
2022-12-31 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 376,004 9.900% |
166,004 (+79.05%) |
Filing History |
| 2023-02-07 4:42 pm Sale |
2022-12-31 | 13G | BioRestorative Therapies, Inc. BRTX |
Hudson Bay Capital Management LP | 0 0.000% |
-200,000 (Position Closed) |
Filing History |
| 2022-07-14 5:26 pm Purchase |
2022-06-30 | 13G | BioRestorative Therapies, Inc. BRTX |
Auctus Fund Management LLC | 210,000 5.800% |
210,000 (New Position) |
Filing History |
| 2022-06-21 10:17 am Purchase |
2022-06-08 | 13D | BioRestorative Therapies, Inc. BRTX |
Broadrick Dale | 611,745 16.800% |
41,561 (+7.29%) |
Filing History |
| 2022-04-07 4:08 pm Purchase |
2022-04-05 | 13D | BioRestorative Therapies, Inc. BRTX |
Broadrick Dale | 570,184 15.700% |
61,700 (+12.13%) |
Filing History |
| 2022-03-29 4:46 pm Purchase |
2022-02-18 | 13D | BioRestorative Therapies, Inc. BRTX |
Broadrick Dale | 508,484 14.600% |
508,484 (New Position) |
Filing History |